Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 1 | $24,642 |
| Sells | 11 | $320,862 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 08 Jul 2024 17:57 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 05 Jul 2024 | Sale | 2,475 | 2.5077 | 6,207 | D |
| 15 May 2024 16:08 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 13 May 2024 | Sale | 8,151 | 4.7888 | 39,034 | D |
| 13 Feb 2024 18:14 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 12 Feb 2024 | Sale | 28,600 | 4.6204 | 132,143 | D |
| 08 Jan 2024 06:03 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 04 Jan 2024 | Sale | 721 | 2.9423 | 2,121 | D |
| 08 Jan 2024 06:03 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 03 Jan 2024 | Sale | 758 | 3.1189 | 2,364 | D |
| 08 Jan 2024 06:03 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 03 Jan 2024 | Sale | 2,261 | 3.1189 | 7,052 | D |
| 13 Dec 2023 16:45 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 11 Dec 2023 | Sale | 12,400 | 4.0212 | 49,863 | D |
| 13 Dec 2023 16:45 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 11 Dec 2023 | Sale | 21,439 | 3.0626 | 65,659 | D |
| 07 Jul 2023 16:08 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 05 Jul 2023 | Sale | 1,361 | 2.4537 | 3,339 | D |
| 05 Jan 2023 20:25 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 05 Jan 2023 | Sale | 729 | 5.4075 | 3,942 | D |
| 05 Jan 2023 20:25 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 04 Jan 2023 | Sale | 1,639 | 5.5756 | 9,138 | D |
| 28 Nov 2022 16:01 | PNT | POINT Biopharma Global Inc | MALIK RAJESH | Director | 28 Nov 2022 | Purchase | 3,700 | 6.66 | 24,642 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)